As the contentious debate on healthcare reform in the United States moves into its third decade, attention has been increasingly focused on the twin realities of value and cost. Greater and greater demands are made upon all therapies (but, most deservingly, on expensive, technology-driven treatments
No takes yet. Share an insight, caveat, or question.
Deluzio et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: